Medical News

RSS

Top prostate cancer surgeon to conduct free men's health screening

On Saturday, February 16, 2013, top prostate cancer surgeon, Dr. David Samadi , will conduct free prostate cancer screenings at the Chian Federation, 4401 Broadway in Astoria, New York 11103.

10 Feb 2013

Research roundup: 'Shared decision making' can reduce costs, improve care; Effects of mental health parity

With shared decision making, patients and their clinicians collaboratively review the risks and benefits of available treatments options while also considering the patients' preferences and values.

10 Feb 2013

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.

10 Feb 2013

Viewpoints: Brewer's stance on Medicaid expansion may signal important shift in GOP; A shrinking government--except for health care

Jan Brewer, Arizona's feisty Republican governor, is better known for wagging her finger at President Obama than for linking arms with him. That's why Brewer's recent announcement that her state intends to join the expansion of Medicaid central to Obama's health care law may represent an important shift. If even Brewer, who has battled repeatedly with Obama, finds the case for expansion compelling, other Republican governors now resisting may also reconsider.

10 Feb 2013

New data on attention and visual perception

The journal PLOS ONE has recently published a study which provides new data around attention and visual perception. The article "A role of eye vergence in covert attention" is signed by led by Hans Supèr, ICREA researcher at the Institute for Brain, Cognition and Behaviour (IR3C) of the University of Barcelona; Maria Solé Puig, J. Antonio Aznar Casanova and Laura Pérez Zapato, all of them researchers at the IR3C, have also participated in the study.

10 Feb 2013

Advocates warn about impact on medical research as debate about automatic cuts continues

Supporters of the National Institutes of Health argue that an anticipated $1.6 billion cut would undermine research in cancer, heart and AIDS, while adding to economic and unemployment woes.

10 Feb 2013

Taro, Sun Pharma mutually agree to terminate merger agreement

Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.

10 Feb 2013

Celgene receives FDA approval for POMALYST to treat multiple myeloma

Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved POMALYST brand therapy (pomalidomide) for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.

10 Feb 2013

Shire, Impax resolve pending generic Adderall XR litigation

Impax Laboratories, Inc. today announced that it has settled all pending litigation with Shire LLC and Shire Laboratories, Inc. relating to supply of its authorized generic Adderall XR under the parties' License and Distribution Agreement that was signed in January 2006.

10 Feb 2013

CEL-SCI reports net loss of $2,310,246 for fiscal quarter ended December 31, 2012

CEL-SCI Corporation reports financial results for the fiscal quarter ended December 31, 2012.

10 Feb 2013

Health care action at state capitols: Hospital fees, abortion, nurses' power to write prescriptions

Lawmakers around the country consider a bevy of bills related to health policy.

10 Feb 2013

Broken motors induce stress and anxiety in mice

When motors break down, getting where you want to go becomes a struggle. Problems arise in much the same way for critical brain receptors when the molecular motors they depend on fail to operate. Now, researchers reporting in Cell Reports, a Cell Press publication, on February 7, have shown these broken motors induce stress and anxiety in mice. The discovery may point the way to new kinds of drugs to treat anxiety and other disorders.

10 Feb 2013

Positive data from POZEN's PA32540 Phase 3 studies presented at AHA 2013 stroke conference

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from the combined results of two Phase 3 studies of PA32540, an antiplatelet therapy of enteric-coated (EC) and immediate-release omeprazole, in patients with previous cerebrovascular disease.

10 Feb 2013

Bronchiectasis independently associated with increased mortality risk in COPD patients

Bronchiectasis is independently associated with an increased mortality risk in patients with moderate-to-severe COPD, according to a new study from researchers in Spain.

10 Feb 2013

International Association of Eating Disorders Professionals to kick off 27th annual symposium

The International Association of Eating Disorders Professionals (iaedp) kicks off its 27th annual Symposium March 21-24 at the Westin Lake Las Vegas Resort and Spa and will feature five nationally recognized professionals addressing new treatments and research concerning eating disorders.

10 Feb 2013

Care Investment Trust enters joint venture with affiliates of Calamar

Care Investment Trust Inc., a real estate investment company that invests in healthcare and seniors-related real estate, today announced that effective as of February 1, 2013, it entered into a joint venture with affiliates of Calamar Enterprises, Inc., owned 75% by affiliates of Care and 25% by affiliates of Calamar, for the acquisition of two senior apartment communities from affiliates of Calamar with an aggregate value of $23.3 million.

10 Feb 2013

Roundup: Conn. governor's budget proposal would shed thousands from Medicaid; Insurance rates to rise 2.7% in Mass.; Calif. group wants tighter doc narcotic control

Gov. Dannel Malloy said he would close Connecticut's $1.2 billion budget gap with a mix of spending cuts, including to hospitals and programs for the poor, and new revenues, including the extension of some business taxes that were scheduled to expire.

10 Feb 2013

MMRF joins multiple myeloma community in celebrating FDA accelerated approval of Pomalyst

The Multiple Myeloma Research Foundation (MMRF) today joined the multiple myeloma community in celebrating the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval of Pomalyst (Celgene Corporation, pomalidomide) for the treatment of patients with relapsed and refractory multiple myeloma who no longer respond to currently available treatments.

10 Feb 2013

Shire commences ABH001 Phase 3 study in Epidermolysis Bullosa

Shire plc, today announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occur in approximately 19 per 1 million live births in the US.

10 Feb 2013

Northwestern Medicine to open new Outpatient Center in Glenview, Illinois

Northwestern Medicine today announced that on March 1 it will open a new Outpatient Center at 2701 Patriot Boulevard in Glenview, Illinois. At this new center, 20-30 physicians will offer patients a wide range of primary care and specialty clinical services.

10 Feb 2013

Medical News

Top prostate cancer surgeon to conduct free men's health screening

Research roundup: 'Shared decision making' can reduce costs, improve care; Effects of mental health parity

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

Viewpoints: Brewer's stance on Medicaid expansion may signal important shift in GOP; A shrinking government--except for health care

New data on attention and visual perception

Advocates warn about impact on medical research as debate about automatic cuts continues

Taro, Sun Pharma mutually agree to terminate merger agreement

Celgene receives FDA approval for POMALYST to treat multiple myeloma

Shire, Impax resolve pending generic Adderall XR litigation

CEL-SCI reports net loss of $2,310,246 for fiscal quarter ended December 31, 2012

Health care action at state capitols: Hospital fees, abortion, nurses' power to write prescriptions

Broken motors induce stress and anxiety in mice

Positive data from POZEN's PA32540 Phase 3 studies presented at AHA 2013 stroke conference

Bronchiectasis independently associated with increased mortality risk in COPD patients

International Association of Eating Disorders Professionals to kick off 27th annual symposium

Care Investment Trust enters joint venture with affiliates of Calamar

Roundup: Conn. governor's budget proposal would shed thousands from Medicaid; Insurance rates to rise 2.7% in Mass.; Calif. group wants tighter doc narcotic control

MMRF joins multiple myeloma community in celebrating FDA accelerated approval of Pomalyst

Shire commences ABH001 Phase 3 study in Epidermolysis Bullosa

Northwestern Medicine to open new Outpatient Center in Glenview, Illinois

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News